"GREENWICH, Connecticut, June 8, 2017 /PRNewswire/ --
Provides range of discovery, CMC and non-clinical services
Dr. Jonathan Goldman, CEO, Aptuit LLC, announced a strategic provider relationship between Aptuit, a leading Partnership Research Organization, and Regulus Therapeutics Inc (RGLS), an innovative biopharmaceutical company. The agreement includes a broad range of discovery and development services to support Regulus programs targeting microRNAs...."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.